Stratos Wealth Partners’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-8,812
Closed -$237K – 1159
2022
Q2
$237K Buy
8,812
+150
+2% +$4.82K 0.01% 1030
2022
Q1
$339K Sell
8,662
-49
-0.6% -$1.9K 0.01% 946
2021
Q4
$399K Sell
8,711
-825
-9% -$39.4K 0.01% 899
2021
Q3
$452K Sell
9,536
-100
-1% -$4.67K 0.01% 788
2021
Q2
$447K Hold
9,636
– – 0.01% 811
2021
Q1
$423K Sell
9,636
-145
-1% -$6.58K 0.01% 763
2020
Q4
$402K Hold
9,781
– – 0.01% 743
2020
Q3
$365K Sell
9,781
-1,990
-17% -$73.3K 0.01% 719
2020
Q2
$405K Sell
11,771
-140
-1% -$4.35K 0.01% 669
2020
Q1
$333K Sell
11,911
-2,854
-19% -$95K 0.02% 656
2019
Q4
$513K Sell
14,765
-14,777
-50% -$500K 0.02% 586
2019
Q3
$953K Sell
29,542
-1,093
-4% -$37.4K 0.04% 376
2019
Q2
$1.05M Sell
30,635
-80
-0.3% -$2.7K 0.05% 357
2019
Q1
$1.03M Sell
30,715
-5,185
-14% -$163K 0.05% 353
2018
Q4
$992K Sell
35,900
-1,844
-5% -$57.2K 0.05% 330
2018
Q3
$1.45M Buy
37,744
+23,680
+168% +$871K 0.06% 268
2018
Q2
$494K Buy
14,064
+1,600
+13% +$55.8K 0.02% 571
2018
Q1
$415K Buy
+12,464
New +$424K 0.02% 610

Other funds holding FFTY

Stratos Wealth Partners's FFTY Position: Q3 2022 in Review

Stratos Wealth Partners sold out of CapForce IBD 50 ETF (FFTY) in Q3 2022, closing a stake of 8,812 shares — an estimated $237K sold.

Stratos Wealth Partners first reported a position in FFTY in Q1 2018 and held it in 18 quarters. The position peaked at $1.45M in Q3 2018. 50 funds tracked by Wall St. Rank hold FFTY as of Q3 2022.

  • Stratos Wealth Partners reported no remaining CapForce IBD 50 ETF position as of Q3 2022 after selling out during the quarter.
  • Stratos Wealth Partners sold 8,812 CapForce IBD 50 ETF shares in Q3 2022, an estimated $237K.
  • Stratos Wealth Partners first reported a position in CapForce IBD 50 ETF in Q1 2018 and held it in 18 quarters.
  • Stratos Wealth Partners's CapForce IBD 50 ETF position peaked at $1.45M in Q3 2018.
  • 50 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2022.

Based on Stratos Wealth Partners's 13F filing for Q3 2022, filed 24 Oct 2022.